The Indiana Methodist Research Institute Cancer Research Laboratory has published three studies related to "Ganoderma lucidum inhibits breast cancer" in the past six months.
Their research suggests that Ganoderma lucidum can reduce the expression of "estrogen receptor" and inhibit NF-KappaB molecular activity through various effects, including inhibition of Akt / NF-KappaB signaling in cells, In the quiescent state, there is no unrestricted replication hyperplasia. (MCF-7) or non-estrogen-induced breast cancer cells (MDA-MB-231) are effective in the treatment of these mechanisms.
Ganoderma supplier, ganoderma manufacture.
In addition, even low-invasive cancer cells are affected by oxidative stress and metastasis. The laboratory study confirmed that Ganoderma lucidum through molecular information regulation, and inhibition of the formation of mediator 8, reduce the pressure of cancer caused by the transfer of cancer opportunities.
In view of the above-mentioned efficacy, the laboratory believes that Ganoderma lucidum is very suitable for the treatment of breast cancer, they even suggested that in the Ganoderma lucidum extract by adding green tea extract, for the control of invasive and metastatic strong breast cancer cells MDA- MB-231, it is complement each other.